Literature DB >> 17553976

Nuclease-resistant single-stranded DNA controls for nucleic acid amplification assays.

Antje Gotsch1, Andreas Schubert, Armin Bombis, Michael Wiedmann, Michael Zauke, Stefan Schorling.   

Abstract

Molecular diagnostic tests based on the PCR or alternative nucleic acid amplification technologies are commonly used for pathogen screening at blood drawing centers. Contrived process surveillance using test-specific external and internal controls is critical for the efficient leverage of PCR power. We describe here novel control constructs for use in nucleic acid amplification assays for pathogens with a single-stranded DNA genome, e.g., parvovirus B19. These controls are derived from a deletion mutant of the filamentous phage fd-tet, fKN16, and consist of single-stranded DNA packaged in a protein coat. They are essentially noninfectious to Escherichia coli and highly resistant to nuclease degradation. fKN16 based controls can be readily manufactured and highly purified. Despite their confirmed filamentous morphology, they can be precisely and accurately diluted over a wide range. Stability studies reveal that the novel control constructs are highly resistant to temperature stress, regardless of whether they are tested as concentrated stocks in storage buffer or diluted in buffer or human plasma. Real-time amplification curves derived from recombinant control constructs containing a parvovirus B19 specific sequence fragment match those derived from native virus. In summary, our data demonstrate the feasibility of novel nuclease-resistant single-stranded DNA controls as surrogates for parvovirus B19 and their applicability in routine molecular diagnostics.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17553976      PMCID: PMC1951227          DOI: 10.1128/JCM.00647-07

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  14 in total

Review 1.  Parvovirus B19.

Authors:  Neal S Young; Kevin E Brown
Journal:  N Engl J Med       Date:  2004-02-05       Impact factor: 91.245

Review 2.  Detection and quantitation of parvovirus B19.

Authors:  Kevin E Brown
Journal:  J Clin Virol       Date:  2004-09       Impact factor: 3.168

3.  Armored RNA technology for production of ribonuclease-resistant viral RNA controls and standards.

Authors:  B L Pasloske; C R Walkerpeach; R D Obermoeller; M Winkler; D B DuBois
Journal:  J Clin Microbiol       Date:  1998-12       Impact factor: 5.948

4.  Detection of human parvovirus B19 DNA in plasma pools and blood products derived from these pools: implications for efficiency and consistency of removal of B19 DNA during manufacture.

Authors:  J Saldanha; P Minor
Journal:  Br J Haematol       Date:  1996-06       Impact factor: 6.998

5.  Ribonuclease-resistant RNA controls (Armored RNA) for reverse transcription-PCR, branched DNA, and genotyping assays for hepatitis C virus.

Authors:  C R WalkerPeach; M Winkler; D B DuBois; B L Pasloske
Journal:  Clin Chem       Date:  1999-12       Impact factor: 8.327

6.  Parvovirus B19 transmission by a high-purity factor VIII concentrate.

Authors:  Chuan-ging Wu; Bobby Mason; Julia Jong; Dean Erdman; Laurel McKernan; Meredith Oakley; Mike Soucie; Bruce Evatt; Mei-ying W Yu
Journal:  Transfusion       Date:  2005-06       Impact factor: 3.157

Review 7.  Nucleic acid testing for emerging viral infections.

Authors:  J-P Allain; I Thomas; S Sauleda
Journal:  Transfus Med       Date:  2002-08       Impact factor: 2.019

8.  Quantification of parvovirus B19 DNA using COBAS AmpliPrep automated sample preparation and LightCycler real-time PCR.

Authors:  Stefan Schorling; Gunnar Schalasta; Gisela Enders; Michael Zauke
Journal:  J Mol Diagn       Date:  2004-02       Impact factor: 5.568

9.  Gene-III protein of filamentous phages: evidence for a carboxyl-terminal domain with a role in morphogenesis.

Authors:  J W Crissman; G P Smith
Journal:  Virology       Date:  1984-01-30       Impact factor: 3.616

10.  Life-threatening human parvovirus B19 infection transmitted by intravenous immune globulin.

Authors:  Fumihiko Hayakawa; Kazumi Imada; Masayuki Towatari; Hidehiko Saito
Journal:  Br J Haematol       Date:  2002-09       Impact factor: 6.998

View more
  4 in total

Review 1.  Design of virus-based nanomaterials for medicine, biotechnology, and energy.

Authors:  Amy M Wen; Nicole F Steinmetz
Journal:  Chem Soc Rev       Date:  2016-07-25       Impact factor: 54.564

2.  Internal control for nucleic acid testing based on the use of purified Bacillus atrophaeus subsp. globigii spores.

Authors:  François J Picard; Martin Gagnon; Marthe R Bernier; Nicholas J Parham; Martine Bastien; Maurice Boissinot; Régis Peytavi; Michel G Bergeron
Journal:  J Clin Microbiol       Date:  2009-01-14       Impact factor: 5.948

3.  Nuclease-resistant double-stranded DNA controls or standards for hepatitis B virus nucleic acid amplification assays.

Authors:  Shuang Meng; Sien Zhan; Jinming Li
Journal:  Virol J       Date:  2009-12-22       Impact factor: 4.099

4.  Optimization of PCR for quantification of simian immunodeficiency virus genomic RNA in plasma of rhesus macaques (Macaca mulatta) using armored RNA.

Authors:  C J Monjure; C D Tatum; A T Panganiban; M Arainga; V Traina-Dorge; P A Marx; E S Didier
Journal:  J Med Primatol       Date:  2013-11-22       Impact factor: 0.667

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.